Antibiotice S.A. (BVB:ATB)
Romania
· Delayed Price · Currency is RON 2.075
-0.005 (-0.24%)
At close: Apr 28, 2025
Antibiotice Revenue
In the year 2024, Antibiotice had annual revenue of 686.57M RON with 11.58% growth. Antibiotice had revenue of 170.04M in the quarter ending December 31, 2024, with 20.28% growth.
Revenue
686.57M
Revenue Growth
+11.58%
P/S Ratio
2.03
Revenue / Employee
508.57K
Employees
1,350
Market Cap
1.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 686.57M | 71.28M | 11.58% |
| Dec 31, 2023 | 615.29M | 110.29M | 21.84% |
| Dec 31, 2022 | 505.00M | 126.17M | 33.31% |
| Dec 31, 2021 | 378.83M | 31.60M | 9.10% |
| Dec 31, 2020 | 347.22M | -47.92M | -12.13% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| S.P.E.E.H. Hidroelectrica | 9.19B |
| OMV Petrom | 34.36B |
| Banca Transilvania | 9.49B |
| SNGN Romgaz | 7.93B |
| BRD - Groupe Société Générale | 3.89B |
| S.N. Nuclearelectrica | 5.93B |
| Digi Communications | 11.60B |
| S.N.T.G.N. Transgaz | 4.43B |